Ocular involvement is associated with HLA-B51 in Adamantiades- Behçet's disease

Eye

Volumn 23, Issue 5, 2009, Pages 1182-1186

  Krause, L ^a   Kohler A K ^a   Altenburg, A ^b   Papoutsis, N ^b   Zouboulis, C C ^b   Pleyer, U ^a   Stroux, A ^a   Foerster, M H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DESSAU MEDICAL CENTER   (Germany)

Author keywords

AdamantiadesBeh ets disease; Epidemiology; HLA B51; Prevalence; Uveitis

Indexed keywords

HLA B51 ANTIGEN;

ADAMANTIADES BEHCET DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; BEHCET DISEASE; CHILD; CLINICAL EVALUATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GERMANY; GROUPS BY AGE; HUMAN; HYPOPYON; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; PAPILLITIS; RETINA VASCULITIS; RETROSPECTIVE STUDY; TURKEY (REPUBLIC); UVEITIS; VASCULAR DISEASE;

ADOLESCENT; ADULT; BEHCET SYNDROME; CHILD; CHILD, PRESCHOOL; EYE DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-B ANTIGENS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 65949093502     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.177     Document Type: Article

References (37)

1. Zouboulis CC, May T. Pathogenesis of Adamantiades- Behcet's disease. Adv Exp Med Biol 2003; 528: 161-171.
2. Yazici H, Fresko I, Yurdakul S. Behcet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007; 3: 148-155.
3. Zierhut M, Mizuki N, Ohno S, Inoko H, Gül A, Onoé K et al. Immunology and functional genomics of Behcet's disease. Cell Mol Life Sci 2003; 60: 1903-1922.
4. Krause L. Adamantiades-Behcet's disease. Ophthalmologe 2005; 102: 329-334.
5. Altenburg A, Papoutsis N, Orawa H, Martus P, Krause L, Zouboulis CC. Epidemiology and clinical manifestations of Adamantiades-Behcet disease in GermanyFcurrent pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges 2006; 4: 49-64; quiz 65-6.
6. Papoutsis NG, Abdel-Naser MB, Altenburg A, Orawa H, Kötter I, Krause L et al. Prevalence of Adamantiades-Becet's disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin Exp Rheumatol 2006; 24: 125.
7. Fresko I, Soy M, Hamuryudan V, Yurdakul S, Yavuz S, Tümer Z et al. Genetic anticipation in Behcet's syndrome. Ann Rheum Dis 1998; 57: 45-48.
8. Zouboulis CC. Epidemiology of Adamantiades-Behcet's disease. Ann Med Interne (Paris) 1999; 150: 488-498.
9. Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Oschsendorf FR et al. Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe. Yonsei Med J 1997; 38: 411-422.
10. Kotter I, Vonthein R, Muller CA, Gunaydin I, Zierhut M, Stubiger N. Behcet's disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 2004; 31: 133-139.
11. Direskeneli H. Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 2001; 60: 996-1002.
12. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990; 335: 1078-1080.
13. Akpolat T, Koc Y, Yeniay I et al. Familial Behcet's disease. Eur J Med 1992; 1: 391-395.
14. Arber N, Klein T, Meiner Z, Pras E, Weinberger A. Close association of HLA-B51 and B52 in Israeli patients with Behcet's syndrome. Ann Rheum Dis 1991; 50: 351-353.
15. Gurler A, Boyvat A, Tursen U. Clinical manifestations of Behcet's disease: an analysis of 2147 patients. Yonsei Med J 1997; 38: 423-427.
16. Kone-Paut I, Geisler I, Wechsler B, Ozen S, Ozdogan H, Rozenbaum M et al. Familial aggregation in Behcet's disease: high frequency in siblings and parents of pediatric probands. J Pediatr 1999; 135: 89-93.
17. Nishiyama M, Nakae K, Umehara T. A study of familial occurrence of Behcet's disease with and without ocular lesions. Jpn J Ophthalmol 2001; 45: 313-316.
18. Nishiyama M, Nakae K, Kuriyama T, Hashimoto M, Hsu ZN. A study among related pairs of Japanese patients with familial Behcet's disease: group comparisons by interval of disease onsets. J Rheumatol 2002; 29: 743-747.
19. Gul A, Inanc M, Ocal L, Aral O, Konice M. Familial aggregation of Behcet's disease in Turkey. Ann Rheum Dis 2000; 59: 622-625.
20. Suzuki Kurokawa M, Suzuki N. Behcet's disease. Clin Exp Med 2004; 4: 10-20.
21. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999; 54: 213-220.
22. Atmaca LS. Fundus changes associated with Behcet's disease. Graefes Arch Clin Exp Ophthalmol 1989; 227: 340-344.
23. Kaneko S, Suzuki N, Yamashita N, Nagafuchi H, Nakajima T, Wakisaka S et al. Characterization of Tcells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan. Clin Exp Immunol 1997; 108: 204-212.
24. Yamashita N, Kaneoka H, Kaneko S, Takeno M, Oneda K, Koizumi H et al. Role of gammadelta T lymphocytes in the development of Behcet's disease. Clin Exp Immunol 1997; 107: 241-247.
25. Yamashita N. Hyperreactivity of neutrophils and abnormal T cell homeostasis: a new insight for pathogenesis of Behcet's disease. Int Rev Immunol 1997; 14: 11-19.
26. Boyd SR, Young S, Lightman S. Immunopathology of the noninfectious posterior and intermediate uveitides. Surv Ophthalmol 2001; 46: 209-233.
27. Kera J, Mizuki N, Ota M, Katsuyama Y, Pivetti-Pezzi P, Ohno S et al. Significant associations of HLA-B*5101 and B5108, and lack of association of class II alleles with Behcet's disease in Italian patients. Tissue Antigens 1999; 54: 565-571.
28. Pirim I, Atasoy M, Ikbal M, Erdem T, Aliagaoglu C. HLA class I and class II genotyping in patients with Behcet's disease: a regional study of eastern part of Turkey. Tissue Antigens 2004; 64: 293-297.
29. Mizuki N, Ota M, Katsuyama Y, Yabuki K, Ando H, Goto K et al. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behcet's disease. Arthritis Rheum 1999; 42: 1961-1966.
30. Yabuki K, Mizuki N, Ota M, Katsuyama Y, Palimeris G, Stavropoulos C et al. Association of MICA gene and HLA-B5101 with Behcet's disease in Greece. Invest Ophthalmol Vis Sci 1999; 40: 1921-1926.
31. de Smet MD, Yamamoto JH, Mochizuki M, Gery I, Singh VK, Shinohara T et al. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol 1990; 110: 135-142.
32. Wildner G, Diedrichs-Mohring M, Thurau SR. Induction of arthritis and uveitis in Lewis rats by antigenic mimicry of peptides from HLA-B27 and cytokeratin. Eur J Immunol 2002; 32: 299-306.
33. Wildner G, Thurau SR. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: aclue to major histocompatibility complex association with autoimmune disease. Eur J Immunol 1994; 24: 2579-2585.
34. Zouboulis CC, Turnbull JR, Martus P. Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Behçet's Disease. In: Zouboulis CC (ed). Adamantiades-Behçet's Disease. Kluwer/Plenum: London Amsterdam, 2003; 123-126.
35. Takeuchi M, Hokama H, Tsukahara R, Kezuka T, Goto H, Sakai J et al. Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol 2005; 243(11): 1147-1152.
36. Kilmartin DJ, Finch A, Acheson RW. Primary association of HLA-B51 with Behçet's disease in Ireland. Br J Ophthalmol 1997; 81(8): 649-653.
37. Verity DH, Wallace GR, Vaughan RW, Kondeatis E, Madanat W, Zureikat H et al. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. Tissue Antigens 1999; 54(3): 264-272.